Breaking News

A new CRISPR startup draws big-name backers; a major health care player faces a crossroads

   

 

Pharmalot Ed Silverman

STAT+: New CRISPR startup, drawing big-name backers, seeks to fix diseases caused by large DNA errors

By Allison DeAngelis

Adobe

The company, Tome Biosciences, is backed by Arch Venture Partners, Andreessen Horowitz, and the Longwood Fund.

Read More

Is the Covid-19 pandemic over? The answer is more art than science

By Helen Branswell

Alex Hogan/STAT

Reaching the end of a pandemic is not like driving out of one county into the next — there is no fixed demarcation.

Read More

STAT+: Minimal compliance, or meaningful change? Epic faces a crossroads as new rules put pressure on health data sharing

By Casey Ross and Mohana Ravindranath

Molly Ferguson for STAT

STAT spoke with dozens of researchers, developers, and health system leaders about Epic’s outsize influence on health data sharing.

Read More

Opinion: Hospital financing in black and white

By Gracie Himmelstein and Joniqua Ceasar and Kathryn E.W. Himmelstein

Adobe

Hospitals caring for large shares of Black patients were paid $283 less for each day of a hospital stay compared to other hospitals.

Read More

Tuesday, September 20, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments